Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CP Kelco UK Ltd

CP Kelco is the innovation leader in the production of polysaccharides by microbial fermentation, extraction from land and sea plants, and modification of cellulose-based raw materials. CP Kelco’s goal is to be the preferred partner for providing innovative products and solutions through the use of nature-based chemistry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

CP Kelco UK Ltd
Cleeve Court, Cleeve Road, Leatherhead, Surrey, KT22 7UD
+44  (0) 1372 369 400
Contact CP Kelco UK Ltd
Website

 Latest Content from PMHub 

Innovative Trials nominated finalist at the Pharma Industry Award

Press Releases | August 23, 2024 | Innovative Trials

Patient recruitment company, Innovative Trials, has been nominated as a finalist in 2 categories at the Pharma Industry Award Read the full press release 👉🏽 https://bit.ly/3MdzBwf

EatMoreFruit Selected by European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) to Lead Strategic PR and Communications for European Laboratory Day

Press Releases | August 23, 2024 | EatMoreFruit

The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has selected London-based healthcare specialist EatMoreFruit to raise awareness and engagement around its ‘EU Lab Day’; an event co-ordinating 42...

Time and Cost Savings with Virtual Medical Education – Perks of Virtual Medical Education

Videos and Podcasts | August 22, 2024 | Impetus Digital

Step into the future of medical education with significant time and cost savings! Virtual learning allows healthcare professionals to engage in training without travel, cutting costs and conserving valuable work...

Measuring success: our key highlights from BrightonSEO

Press Releases | August 20, 2024 | Wallace Health

Attending BrightonSEO allows us to keep up to date with some of the latest developments and forward thinking in content marketing. It’s the biggest search marketing conference in the world,...

Pharma-exclusive Webinar: Virtual Publication Planning, Co-Development, & Reviews

Press Releases | August 15, 2024 | Impetus Digital

Dive into Impetus Digital's exclusive webinar on Medical Publications to learn from experts about the latest in publication planning, co-development, and reviews, and enhance your strategies in the virtual realm.

Boosting Memory with Frequent Virtual Touchpoints – Perks of Virtual Medical Education

Videos and Podcasts | August 15, 2024 | Impetus Digital

Unlock the secrets to effective learning with our latest video! Learn how frequent, short virtual sessions utilize the Recency Effect to improve memorization and avoid fatigue, outperforming long, one-time meetings....

Unveiling the truth: A journey into women’s representation in clinical trials

White Papers and Resources | August 14, 2024 | Cuttsy + Cuttsy

We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.

NHS winter planning 2024–25 – Engaging with NHS decision-makers between now and Christmas

Press Releases | August 13, 2024 | Petauri Evidence

How is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and support NHS decision-makers in the next few months?...

Avoid Costly Clinical Trial Adjustments with Origins – This Simple Solution Will Change Everything!

Press Releases | August 13, 2024 | Origins – The Patient Focused Specialists

Low recruitment and retention rates in clinical trials can lead to costly protocol adjustments and trial delays. Visit the Origins Knowledge Centre and watch our latest video to discover how...

Patient Recruitment & Retention Webinar for Influenza Studies

Press Releases | August 12, 2024 | Innovative Trials

Join the upcoming webinar which will discuss key patient recruitment & retention challenges and solutions for upcoming influenza studies.